Qatar’s Vision 2030 Puts Science and Innovation Front and Center

Qatar emphasized science, technology, and innovation as top priorities under its National Vision 2030. This message took center stage during the Qatar-Italy Biotechnology and Science Forum, held in Doha. Organized by the Ministry of Commerce and Industry, in collaboration with the Qatar Chamber, the event brought together key stakeholders from both nations. It aimed to strengthen collaboration and create new opportunities in biotechnology, health, and life sciences.

Qatar also unveiled a QR20 billion investment package to accelerate development in biotechnology, artificial intelligence, and other emerging technologies. This initiative aims to drive innovation through public-private partnerships, increase venture capital activity, and improve the overall investment climate. Furthermore, the government is actively reforming business regulations and introducing a range of incentives—including tax breaks, competitive lease rates, and low energy costs. These measures are particularly appealing to startups and international investors looking to enter the Qatari market.

Expanding Qatar-Italy Collaboration

Qatar and Italy have seen trade volumes surpass $24 billion over the last five years, with over 350 Italian companies currently active in Qatar across various sectors. The forum emphasized deepening this cooperation, especially in high-tech and research-driven industries. Moreover, Italian institutions and companies shared their expertise, positioning Italy as a valuable partner in driving growth and innovation in Qatar’s expanding biotech and life sciences ecosystem.

Opportunities for Startups and Entrepreneurs

The forum served as a dynamic platform for startups and entrepreneurs to explore opportunities in funding, incubation, and business expansion. Key organizations like Invest Qatar, the Qatar Free Zones Authority, and the Qatar Financial Center delivered presentations showcasing the country’s strong support system for early-stage ventures. They highlighted Qatar’s simplified business setup processes, the possibility of 100% foreign ownership in specific zones, and the strategic advantages offered by its location for reaching global markets.

Startups in healthcare, biopharma, and medical technology received strong encouragement to engage with Qatar’s expanding innovation ecosystem. Key institutions such as the Qatar Biomedical Research Institute, Qatar Precision Health Institute, and Sidra Hospital play a central role in this landscape. They provide valuable opportunities for research collaboration, pilot testing of new solutions, and support for bringing products to market.

Italy’s Advanced Biotech Ecosystem

Italy brings together a strong industrial foundation, cutting-edge research capabilities, and robust government backing, positioning itself as one of Europe’s top biotech hubs. During the forum, the Italian delegation actively presented insights into the country’s vibrant startup ecosystem, research and development frameworks, and international growth strategies. The Doha stop of the Montalcini Biotech Tour 2025 highlighted Italy’s commitment to innovation and its openness to global collaboration, particularly in the health and life sciences sectors.

Speakers from Italy's Ministry of Foreign Affairs and CDP Venture Capital outlined practical ways to support cross-border entrepreneurship and unlock funding opportunities. Their contributions helped position the forum as a vital space for networking, building partnerships, and launching joint projects between Italian and Qatari innovators.